News Research Operational Efficiency

Ambient AI Scribe Use in Oncology Study at Memorial Sloan Kettering Cancer Center

November 10, 2026 By ASCO AI Staff 10 min watch
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

Abigail Baldwin-Medsker, MBA, MSN, RN, Senior Director of Quality Optimization & Innovation at Memorial Sloan Kettering Cancer Center, elaborates about her presentation of a prospective study on ambient AI scribe usage among oncology professionals from the 2026 ASCO Quality Care Symposium. When an ambient AI scribe tool was rolled out at Memorial Sloan Kettering Cancer Center, adoption increased over time as newer support strategies were implemented and satisfaction with the tool was overall positive. Usage and effects varied by clinician and visit characteristics.

Related Content